Document is current
Any future updates will be listed below
-
Authors
den Bakker, C. M. http://orcid.org/0000-0002-2228-517X
Schaafsma, F. G.
Huirne, J. A. F.
Consten, E. C. J.
Stockmann, H. B. A. C.
Rodenburg, C. J.
de Klerk, G. J.
Bonjer, H. J.
Anema, J. R.
-
Funding
Funding for this research was provided by:
ZonMw (837002409)
- License Information
-
More Information
Article History
Received: 26 November 2017
Accepted: 16 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: The medical ethics committee of the VU University medical center approved the protocol in 2015 (registration number 2014.364). Written informed consent to participate was obtained from all study participants.
: Informed consent for publication was obtained from all study participants. Identifying information is not applicable given the information is anonymized and encrypted.
: CdB, FS, EC, HS, CR, GdK and HB have no conflicts of interest. JA and JH intend to set up a spin-off company concerning the implementation of a mobile application concerning the IKHERSTEL intervention in the Netherlands. JH received grants from NWO, ZonMw and Samsung, during the conduct of the study and received a fee from Olympus, outside the submitted work. JA holds a chair in Insurance Medicine paid by the Dutch Social Security Agency, he is stockholder of Evalua and received grants from ZonMw/NWO, Instituut Gak, UWV, SZW, VWS, Pfizer, Achmea, CVZ/Zorg Instituut outside the submitted work. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
